APA način citiranja

Pithadia, D., Treichel, A., Jones, A., Julien-Williams, P., Machado, T., Moss, J., & Darling, T. (2020). Dermatologic adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex. Br J Dermatol.

Čikaški stil citiranja

Pithadia, D.J., A.M Treichel, A.M Jones, P. Julien-Williams, T. Machado, J. Moss, i T.N Darling. "Dermatologic Adverse Events Associated With Use of Oral Mechanistic Target of Rapamycin Inhibitors in a Cohort of Individuals With Tuberous Sclerosis Complex." Br J Dermatol 2020.

MLA način citiranja

Pithadia, D.J., et al. "Dermatologic Adverse Events Associated With Use of Oral Mechanistic Target of Rapamycin Inhibitors in a Cohort of Individuals With Tuberous Sclerosis Complex." Br J Dermatol 2020.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.